Introduction
Ancistrocladus abbreviatus Airy Shaw (Ancistrocladaceae)
1-3 is a West African scandent shrub abundantly occurring in wet evergreen forests, along roadsides, river banks, and islands. In the juvenile phase, the plants start growing as erect, selfsupporting saplings with leaves arranged in terminal rosettes. Reaching maturity, they form climbing stems from elongated shoots that bear vegetative, oen robust leaves. Adult specimens can reach a height of more than 6 m, supported by means of recurved to spiraling woody hooks, as typical of the Ancistrocladaceae.
1,4
Phytochemical studies on A. abbreviatus collected in the Parc National de Taï, Southwestern Côte d'Ivoire (Ivory Coast), resulted in the discovery of ca. 30 structurally most diverse naphthylisoquinoline alkaloids displaying four different coupling types (5,1 0 , 7,1 0 , 5,8 0 , and 7,8 0 ). [5] [6] [7] [8] [9] [10] [11] The metabolic pattern of this West African plant is strongly dominated by the presence of 5,1 0 -and 7,1 0 -linked naphthylisoquinolines. All of the alkaloids with a 5,1 0 -biaryl linkage constitute typical Ancistrocladaceae-type compounds 5, 12 like e.g., ancistrobrevine E (1) (Fig. 1) , i.e., with S-conguration at C-3 and an oxygen function at C-6.
5,6,10,11 Most of the 7,1 0 -coupled alkaloids of A.
abbreviatus, by contrast, among them the two main constituents, N-methyldioncophylline A (9a) and its atropodiastereomer 9b (Fig. 1) , are 3R-congured and lack an oxygen substituent at C-6.
5,9,10
They are thus categorized as Dioncophyllaceae-type compounds, 5, 12 because the only other plant family that likewise produces naphthylisoquinoline alkaloids, the Dioncophyllaceae, 13 exclusively forms alkaloids with these two structural features. 5, 12, 14 They are -similar to A. abbreviatus -endemic to West Africa. [1] [2] [3] 13 Remarkably, only two 5, 8 0 -coupled alkaloids, ancistrobrevine B (2) and its 5 0 -O-demethyl analog 3 ( Fig. 1 ), have so far been detected in A. abbreviatus, 6, 11 whereas naphthylisoquinoline alkaloids of this coupling type are the most prevalent ones in Central African Ancistrocladus lianas.
5,12,15-25
Ancistrocladus abbreviatus furthermore contains a substantial number of representatives (six compounds) of the otherwise rare group of 7, 8 0 -linked naphthylisoquinoline alkaloids, one of them is ancistrobrevine I (11) (Fig. 1) . 10, 11 All of the 5,8 0 -and 7,8 0 -coupled alkaloids are typical Ancistrocladaceae-type compounds.
The by far largest group of constituents of A. abbreviatus are naphthyltetrahydroisoquinolines, [5] [6] [7] [9] [10] [11] whereas only four of the alkaloids had a dihydroisoquinoline subunit, among them compound 11.
8,11
Here, we describe the isolation and structural elucidation of an unprecedented series of minor metabolites possessing a fully dehydrogenated isoquinoline half. The series comprises four new compounds, named ancistrobreveines A-D (12-14, and 6) and the two previously known 26,27 naphthylisoquinolines 6-Omethylhamateine (4) and ent-dioncophylleine A (10) (Fig. 1 ).
Since they were devoid of any stereogenic centers, the only element of chirality in these compounds was the rotationally hindered biaryl axis.
Fully dehydrogenated naphthylisoquinoline alkaloids have as yet been found quite rarely in nature. Prior to this work, only 14 such compounds (out of a total of more than 250 known naphthylisoquinoline alkaloids) had been identied in Ancistrocladus lianas, most of them from Asian taxa. 20, 21, [26] [27] [28] [29] [30] Only recently, phytochemical studies on the Congolese liana A. likoko has shown the presence of fully dehydrogenated naphthylisoquinolines for the rst time in an African species, too.
20,21
Each of the six alkaloids discovered in A. abbreviatus was obtained in an optically active form, initially leaving open whether they were enantiomerically pure or just scalemic. Analysis by HPLC chromatography on a chiral phase in combination with ECD spectroscopy revealed all of them to be enantiopure, except for one of the alkaloids, the new 7,8 0 -linked ancistrobreveine C (14) . This compound was found to be produced as an atropo-enantiomeric mixture, with the P-enantiomer being the by far major one occurring in the plant. Likewise noteworthy, compounds 12-14 are the rst 7,1 0 -and 7,8 0 -coupled Ancistrocladaceae-type alkaloids found in nature that possess a fully dehydrogenated isoquinoline subunit. Some of the dehydrogenated alkaloids isolated from other Ancistrocladus species, such as ancistrobenomine B (5) and the ancistrolikokines G (7) and J 2 (8) (Fig. 1) , have attracted attention due to their strong antiproliferative activities against human drug-sensitive CCRF-CEM leukemia cells and their multidrug-resistant subline, CEM/ADR5000, similar to the Fig. 1 Naphthylisoquinolines from the roots of the West African shrub Ancistrocladus abbreviatus displaying four different coupling types, among them a unique series of six metabolites belonging to the small subgroup of alkaloids with a fully dehydrogenated isoquinoline portion, the four new ancistrobreveines A (12), B (13), C (14) , and D (6), and two previously known 26, 27 alkaloids, 6-O-methylhamateine (4) and ent-dioncophylleine A (10); ancistrobenomine B (5) and the ancistrolikokines G (7) and J 2 (8) are examples of fully dehydrogenated naphthylisoquinoline alkaloids displaying strong antiproliferative activities against leukemia cells.
21,30
effects induced by the established anticancer drug doxorubicin. 21, 30 These ndings prompted us to evaluate the cytotoxic potential of the six alkaloids of A. abbreviatus presented in this paper. The results provide further insight into structural prerequisites for the activities and into the impact of axial chirality on the antileukemic potential of fully dehydrogenated naphthylisoquinoline alkaloids, in particular.
Results and discussion
Isolation and structural elucidation of ancistrobreveines A-D and related naphthylisoquinoline alkaloids An HPLC-UV-MS-guided screening of root bark extracts of A. abbreviatus gave hints at the presence of minor constituents, with UV and MS proles typical of naphthylisoquinoline alkaloids with a non-hydrogenated isoquinoline subunit. For the isolation of these compounds, air-dried ground material of the roots was exhaustively extracted with MeOH-H 2 O (9 : 1, v/v), followed by liquid-liquid partitioning with n-hexane and fractionation of the crude methanolic extract by column chromatography on silica gel. The alkaloid-containing subfractions were directly subjected to preparative reversed-phase HPLC, which permitted isolation of six fully dehydrogenated naphthylisoquinoline alkaloids. Two of them, 6-O-methylhamateine (4) and ent-dioncophylleine A (10), were well known from previous phytochemical studies 26, 27 on related Ancistrocladus species from Southeast Asia.
The 5,1 0 -linked 6-O-methylhamateine (4) had so far been identied only in the leaves of the Vietnamese species A. cochinchinensis, but its enantiomeric purity was never analyzed. 26 HPLC analysis of the material of 4 isolated from the roots of A. abbreviatus on a chiral phase (Lux Cellulose-1) resulted only in one sharp peak (Fig. 2, le) , thus revealing this fully dehydrogenated naphthylisoquinoline to occur in this West African species in an enantiomerically pure form. The ECD spectra recorded at different positions of the peak (e.g., at the le or right slope) were all identical, and virtually opposite to the ECD curve of ancistrocladeine (15) 31 (Fig. 2, right) , a known, likewise fully dehydrogenated and 5,1 0 -coupled, but Pcongured (and 6-O-demethylated) naphthylisoquinoline, previously obtained by semi-synthesis from ancistrocladine.
31,32
With its oxygen function at C-6, 6-O-methylhamateine (4) had the constitution of an Ancistrocladaceae-type naphthylisoquinoline, whereas the constitution of the second known compound isolated from the roots of A. abbreviatus, was categorized as a Dioncophyllaceae-type alkaloid, since it lacked an oxygen group at C-6. Within this classication, the presence or absence of the 6-oxygen function is given priority over the -here not applicable -absolute conguration at C-3.
The second fully dehydrogenated naphthylisoquinoline was readily identied as the 7,1 0 -linked ent-dioncophylleine A (10), which had previously been discovered in the leaves of the Malaysian highland liana A. benomensis. 27 In that species, 10 had been found to be produced in a scalemic form, as a 93 : 7-mixture of 10 and its P-congured enantiomer dioncophylleine A.
5,27,32
The material of 10 isolated from the roots of A. abbreviatus, by contrast, was determined to be enantiomerically pure, as obvious from HPLC analysis on a chiral Lux Cellulose-1 column, giving rise to only one peak (see ESI †), the ECD spectra measured in intervals at different sections of the peak were all identical.
The other four metabolites isolated from the root bark extracts of A. abbreviatus were as yet undescribed.
The rst of these new alkaloids, compound 12, obtained as a yellow amorphous solid, had a molecular formula of C 25 (Fig. 3A) . In the isoquinoline half, the position of the remaining methoxy group was established to be at C-6 as deduced from a NOESY interaction between OMe-6 (d (Fig. 3A) . In the isoquinoline part, the coupling position was deduced to be at C-7 (d C 117.9), based on the NOESY correlation sequence {OMe-6 4 H-5 4 H-4} and on an HMBC interaction from H-5 to C-7. In conclusion, the new compound was a 7,1 0 -coupled alkaloid with a constitution similar to that of ent-dioncophylleine A (10), except for the additional methoxy group at C-6. 27 The absolute conguration of this new Ancistrocladaceaetype naphthylisoquinoline 12 at the biaryl axis was attributed to be P, due to the fact that the new metabolite and 10 displayed nearly identical ECD spectra (Fig. 3B, le) ; for formal reasons, however, the two alkaloids have opposite descriptors, according to the Cahn-Ingold-Prelog denotion. The new fully dehydrogenated naphthylisoquinoline 12 thus possessed the stereostructure presented in Fig. 1 . It was named ancistrobreveine A.
Like in the case of ent-dioncophylleine A (10) isolated from A. abbreviatus, ancistrobreveine A (12) was found to be enantiomerically pure by HPLC-ECD analysis on a chiral phase (Lux Cellulose-1), yielding only one peak (Fig. 3B, le) . The ECD chromatogram monitored for one single wavelength (here at 258 nm, where 12 has a strong negative ECD signal) resulted in one single -and negative -peak. The online ECD spectra obtained from different peak positions were all identical.
HRESIMS analysis of the second new alkaloid, compound 13, gave a molecular formula of C 26 H 27 NO 4 , which thus had 14 mass units more than ancistrobreveine A (12) . Similar to the latter, the new compound 13 again displayed NMR signals (see Table 1 ) typical of a fully dehydrogenated 7,1 0 -coupled naphthylisoquinoline. This metabolite had nearly the same constitution as 12, but possessed a methoxy function (d H 3.92) at C-8 (instead of a hydroxy group as in 12) (Fig. 3A) . Its nearly mirrorimage-like ECD spectrum compared to that of ancistrobreveine A (12) (Fig. 3B , right) revealed the isolated metabolite to exhibit an opposite axial stereo-array. For formal reasons, however, the two compounds had the same P-descriptor according to the Cahn-Ingold-Prelog denotion. Consequently, the new alkaloid had the full stereostructure 13 as presented in Fig. 1 . It was named ancistrobreveine B. Similar as in the case of 12, HPLC analysis on a chiral phase coupled to ECD spectroscopy revealed 13 to occur in the plant in an enantiomerically pure form. According to HRESIMS and 13 C NMR, the third new alkaloid, compound 14, likewise a minor metabolite of the root bark extract, corresponded to a molecular formula of C 26 H 27 NO 4 , identical to that of ancistrobreveine B (13) . NMR spectroscopic data ( In the isoquinoline moiety, C-7 was determined to be the axisbearing carbon atom, as obvious from NOESY interactions in the series {H-4 4 H-5 4 OMe-6} and from HMBC cross peaks to C-7 (d C 128.1), observed for both, the signals of H-5 (d H 7.37) and H-7 0 (d H 7.26). In conclusion, the new alkaloid 14 was a 7,8 0 -coupled naphthylisoquinoline with the constitution shown in Fig. 4A . Its absolute axial conguration was deduced by comparison of its ECD spectrum with those of ent-dioncophylleine A (10)
27
(see ESI †) and ancistrobreveine B (13) (Fig. 4B) , the latter differing from the new alkaloid 14 only by the position of the methyl group on the naphthalene moiety. The inuence of that methyl group on the ECD behavior can be assumed as small compared with that of the large naphthalene chromophore. The ECD spectrum of the new metabolite 14 was nearly identical to that of 13 and virtually opposite to that of 10, which evidenced the biaryl axis of the isolated 7,8 0 -linked alkaloid to be Pcongured. The new compound 14 thus had the full stereostructure presented in Fig. 1 ; it was named ancistrobreveine C. HPLC-UV analysis of 14 on a chiral phase (Lux Cellulose-1) resulted in a nearly unresolved chromatographic peak (Fig. 5A, le) , but the ECD trace of an HPLC run at 255 nm showed a small negative signal at the rising slope of the UVdetected peak and a large positive one on the descending side (see ESI †), thus suggesting that in the plant ancistrobreveine C (14) occurs in a not entirely enantiopure form. This was further conrmed by full LC-ECD spectra recorded online, in stoppedow mode, directly taken at the le slope of the UV peak and at the right one, giving mirror-imaged ECD curves (Fig. 5A) .
Consequently, one enantiomer indeed eluted faster than the other one, but the interactions of the two enantiomers with the adsorbent material were not different enough to achieve a baseline resolution of these two compounds. The more rapidly eluting minor peak (peak A, Fig. 5A , le) was easily identied to correspond to the M-congured enantiomer of ancistrobreveine C, ent-14, as obvious from its ECD curve, which was fully opposite to that of the prevalent enantiomer 14 (peak B, Fig. 5B,  right) . The ratio of the two enantiomers, 14 : ent-14, was determined to be ca. 93 : 7.
As in numerous earlier cases, [33] [34] [35] [36] [37] [38] this nding again demonstrated the usefulness of the hyphenation of HPLC with ECD spectroscopy. This analytical device permitted to reliably distinguish between the two enantiomers of 14, although they (14); (B) assignment of the absolute axial configuration of 14, by comparison of its ECD spectrum with that of the structurally related likewise P-configured, but 7,1 0 -coupled ancistrobreveine B (13, for its structure, see Fig. 1 ).
exhibited only slightly different retention times and were present in quite different concentrations.
Ancistrobreveine C (14) is the as yet only example of a 7,8 0 -linked fully dehydrogenated naphthylisoquinoline alkaloid that is optically active. The only other known alkaloid of this coupling type with a similar molecular framework, dioncophylleine D (16) 27 (Fig. 5B) , a Dioncophyllaceae-type alkaloid isolated from the Malaysian liana A. benomensis, was found to occur as a racemic mixture of its two rapidly interconverting atropo-enantiomers, which are conguratively unstable due to the lack of an oxygen function at C-6. Fig. 6A . Its absolute axial conguration was deduced to be M, since it displayed a virtually mirror-imaged ECD spectrum (Fig. 6B , center) compared to that of the constitutionally identical ancistrolikokine J 3 (ent-6), 21 which is P-congured at the biaryl axis. This alkaloid has only recently been identied in the Congolese liana A. likoko and represents the enantiomer of this 5, 8 0 -linked compound 6 isolated from A.
abbreviatus. The new alkaloid 6 presented here thus had the full absolute stereostructure shown in Fig. 1 . In continuation of the series of fully dehydrogenated metabolites discovered in the roots of A. abbreviatus, it was named ancistrobreveine D.
Investigations on the enantiomeric purity of 6 by chromatography on a chiral phase coupled to ECD spectroscopy resulted in only one peak. The online ECD spectra, which were monitored in intervals at the le and the right slopes of the peak, were all identical. In the plant, ancistrobreveine D (6) was thus present in an enantiopure form, similar to its P-congured enantiomer ancistrolikokine J 3 (ent-6), which was likewise found to be produced stereochemically pure in A. likoko.
Antileukemic activities of the ancistrobreveines A-D and of related fully dehydrogenated naphthylisoquinoline alkaloids
Multi-drug resistance (MDR) leading to recurrent and refractory leukemia is one of the major problems in the treatment of this severe malignancy. 39, 40 Overexpression of Pglycoprotein (P-gp), an ATP-dependent drug pump, is considered to be the most important factor for the development of MDR, because it results in an increased drug efflux and, thus, in a dramatic reduction of intracellular drug concentrations of the antileukemic compounds in the cells. [41] [42] [43] Therefore, the search for novel therapeutic agents to overcome MDR 44, 45 and to efficiently target leukemia is still an urgent task.
More recently, some representatives of naphthylisoquinolines possessing a fully dehydrogenated isoquinoline portion were found to strongly inhibit the viability of drug-sensitive CCRF-CEM leukemic cells and their multidrug-resistant P-gp-overexpressing subline, CEM/ ADR5000.
21,30
In particular, the 5,1 0 -coupled ancistrobenomine B (5) 30 ( Fig. 1 ) from the Chinese liana A. tectorius, additionally equipped with a hydroxymethylene function at C-3, and the 5,8 0 -linked ancistrolikokine G (7) 20,21
( Fig. 1) , a minor metabolite of the Congolese liana A. likoko, attracted attention, since they inhibited cell proliferation at a low micromolar range, revealing only a small degree of cross-resistance, or, as in the case of ancistrolikokine J 2 (8)
21
( Fig. 1) , likewise from A. likoko, even collateral sensitivity.
46
The alkaloid 8 displayed a more pronounced growthretarding activity towards the CEM/ADR5000 cells as compared to that against the parental CCRF-CEM cell line (Table 2) . 21 This nding indicated that these alkaloids may bear a substantial therapeutic potential.
Here, we report on the evaluation of the antileukemic effects of 6-O-methylhamateine (4), ent-dioncophylleine A (10), and the four new ancistrobreveines A-D (12-14, and 6) ( Table 2) , especially focussing on the inuence of the position of the biaryl linkage in these fully dehydrogenated naphthylisoquinoline alkaloids and on the impact of axial chirality on the cytotoxic activities of these compounds.
The lymphoblastic leukemia cells were treated with different concentrations of the respective naphthylisoquinolines in a range from 0.001 to 100 mM or with the reference drug doxorubicin. Cell viability was assessed by the resazurin assay.
Within this series of six naphthylisoquinolines exhibiting four different coupling types ( (4) was by far the most potent compound (Table 2) . Dose-response curves of 4 ( Fig. 7) revealed excellent half-maximum inhibitory concentrations in the low micromolar range towards CCRF-CEM cells (IC 50 ¼ 3.948 mM), and against the resistant CEM/ADR5000 subline (IC 50 ¼ 5.523 mM). The MDR leukemia cell line CEM/ ADR5000, which is known to be highly resistant to the standard drug doxorubicin (ca. 1.770-fold compared to CCRF-CEM), showed only a low degree of cross-resistance for 6-Omethylhamateine (4) (1.4-fold) ( Table 2) , thus indicating that 4 may be a strong and efficient inhibitor also for other drugsensitive cancer cells. Considerable antiproliferative activities against the drugsensitive CCRF-CEM and the multidrug-resistant CEM/ Table 2 ). Its growthinhibitory potential was distinctly lower than that of 4, with an IC 50 value of 12.44 mM determined in CCRF-CEM cells, showing that, in comparison to 4, the cytotoxicity of 14 was reduced down to ca. one third. No cross-resistance was observed for ancistrobreveine C (14) . Its IC 50 values were nearly the same in both cell lines, thus inhibiting the cell viability of sensitive and multidrug-resistant leukemia cells with similar efficacies (Table 2) . The three 7,1 0 -coupled alkaloids ancistrobreveines A (12) and B (13), and ent-dionocophylleine A (10), structurally closely related to the 7,8 0 -linked ancistrobreveine C (14), by contrast, showed only moderate to weak antiproliferative activities against leukemia cancer cells. As outlined in Table  2 , their IC 50 values ranged from 24.8 to 50.6 mM. Ancistrobreveine A (12) even did not display any considerable cytotoxic effect at all against the multidrug-resistant CEM/ ADR5000 subline. Similar to ancistrobreveine C (14), two of the 7,1 0 -coupled compounds, 10 and 13, showed growth inhibitory activities that were nearly the same in both cell lines, thus they did not exhibit any cross-resistances. The previously investigated 5,8 0 -coupled fully dehydrogenated ancistrolikokine G (7), 21 with its particular OH/OMesubstitution pattern in the naphthalene and isoquinoline portions, had displayed strong cytotoxic effects against CCRF-CEM and CEM/ADR5000 leukemia cells, with IC 50 values in the low micromolar range ( Table 2 ). The now isolated O-permethylated ancistrobreveine D (6), by contrast, exhibited only moderate growth-retarding activities: compared to the IC 50 values of ancistrolikokine G (7), 21 the growth-inhibitory potential of compound 6 was reduced by a factor of ca. 5.1 for the drug-sensitive CCRF-CEM cells, and by a factor of ca. 3.8 for the multi-drug resistant subline CEM/ ADR5000. These test results showed that the degree of Omethylation in the two molecular portions may have a distinct impact on the antileukemic activities of 5,8 0 -coupled naphthylisoquinoline alkaloids. The position of the biaryl axis seemed to be of crucial importance, too, as seen from the fact that the 5,1 0 -linked 6-O-methylhamateine (4) strongly inhibited the cell viability of leukemia cells (Fig. 7) , whereas the related 5,8 0 -coupled ancistrobreveine D (6), which, in other words, differed from 4 only by the position of its methyl group in the naphthalene subunit, was only moderately active. In summary, from previous studies 21, 30 and the results presented here, 5,1 0 -and 5,8 0 -coupled alkaloids were the most potent ones among the fully dehydrogenated naphthylisoquinolines tested. Most of these alkaloids were found to inhibit drug-sensitive CCRF-CEM and multidrug-resistant CEM/ADR5000 leukemia cells with nearly similar efficacies, revealing only minimal (ca. 1.2-to 6-fold) or even no crossresistances. With respect to these ndings, the compounds might also serve as promising agents for the treatment of cancer cells unresponsive towards chemotherapeutics routinely used in clinical treatment.
Experimental

General experimental procedures
All organic solvents were of analytical-grade quality. Ultrapure water was obtained from an Elga Purelab Classic system. Optical rotations were measured on a Jasco P-1020 polarimeter operating with a sodium light source (l ¼ 589 nm). UV spectra were recorded on a Shimadzu UV-1800 spectrophotometer. IR spectra were taken on a Jasco FT/IR-410 spectrometer. ECD spectra were acquired on a Jasco J-715 spectropolarimeter at room temperature, using a 0.1 cm standard cell and spectrophotometric-grade MeOH. The ECD data were processed using SpecDis. 47, 48 1D and 2D NMR measurements were performed on a Bruker DMX 600 instrument using methanol-d 4 C, assisted by ultrasonication. The extract was ltered and then concentrated in vacuo. The solid residue was dissolved in MeOH/H 2 O (9 : 1) and repeatedly washed with nhexane to remove the non-polar impurities. The methanolic layer was dried under reduced pressure to yield ca. 17.5 g of a viscous alkaloid-rich solution. It was directly subjected to silica gel column chromatography (CC) using a linear solvent system of MeOH in CH 2 Cl 2 (10 / 80%).
Resolution of fraction F1 (2.1 g) on a SymmetryPrep C18 column, using the solvent systems A and B, with a linear gradient (0 min 26% B, 27 min 65% B), at a ow rate of 10 mL min À1 , furnished some alkaloid-containing subfractions, which were further puried by semi-preparative HPLC on an XSelect HSS PFP column. 
Known alkaloids isolated
The two fully dehydrogenated naphthylisoquinoline alkaloids 6-O-methylhamateine (4) and ent-dioncophylleine A (10) (Fig. 1) , well known from previous phytochemical studies on A. benomensis and A. cochinchinensis, now isolated for the rst time from root bark extracts of A. abbreviatus, were found to be identical in their spectroscopic, physical, and chromatographic behavior with the data reported previously.
26,27
Antileukemic assay
The cytotoxic effects (Table 2 ) of ancistrobreveines A (12), B (13), C (14) , and D (6), 6-O-methylhamateine (4), and ent-dioncophylleine A (10) on drug-sensitive leukemia CCRF-CEM and multidrug-resistant P-glycoprotein-overexpressing CEM/ ADR5000 cells [49] [50] [51] were monitored by the resazurin assay as previously described.
52,53 Doxorubicin (Sigma Aldrich, Munich, Germany) was applied as the positive control, while DMSO, used to dissolve the compounds, was employed as the negative control. The highest concentration of DMSO was less than 1.0%. Fluorescence was measured on an Innite M2000 Pro™ plate reader (Tecan, Crailsheim, Germany), using an excitation wavelength of 544 nm and an emission wavelength of 590 nm. All experiments were performed in triplicate. The viability was evaluated based on the comparison with untreated cells. IC 50 values represent the concentrations of the compounds required to inhibit 50% of cell proliferation. They were calculated from a calibration curve by linear regression using Microso Excel.
54,55
Conclusions
The alkaloid pattern of the West African liana Ancistrocladus abbreviatus is characterized by a remarkable structural diversity, comprising naphthylisoquinoline alkaloids of four different coupling types (5,1 0 , 5,8 0 , 7,1 0 , and 7,8 0 ), 5-11 among them Ancistrocladaceae-type compounds, 5,6,10,11 which are 6-oxygenated and 3S-congured, but also Dioncophyllaceae-type alkaloids 5,9,10 were found, which are deoxygenated at C-6 and have the R-conguration at C-3. Most of them represent naphthyltetrahydroisoquinolines, 5-7,9-11 whereas compounds possessing a dihydroisoquinoline subunit have been isolated much less frequently.
8,11
The newly discovered series of six naphthylisoquinoline alkaloids, presented in this paper, are all equipped with a fully dehydrogenated isoquinoline portion, comprising compounds displaying the four coupling types mentioned above. Four of these metabolites, named ancistrobreveines A-D (12-14, and 6), were identied for the rst time in nature, whereas 6-O-methylhamateine (4) and ent-dioncophylleine A (10) had been known from previous phytochemical studies on related Ancistrocladus species.
26,27
Ancistrobreveine C (14) is the rst example of a 7,8 0 -linked fully dehydrogenated naphthylisoquinoline that is congurationally stable at the biaryl axis. It was found not to occur in an enantiopure form, but accompanied by 7% of its atropo-enantiomer.
The occurrence of such a large series of fully dehydrogenated naphthylisoquinoline alkaloids in a distinct species is remarkable since so far only a total of 14 representatives with such a structural entity had been identied in Ancistrocladaceae lianas, 20, 21, [26] [27] [28] [29] [30] with very few examples from African species in particular. Only the Malaysian highland liana A. benomensis was likewise found to produce such a high number of fully dehydrogenated compounds. 27 Of all of the Ancistrocladus plants investigated so far, 5, 12, 56 among them 16 accepted 5, [15] [16] [17] [19] [20] [21] 23, [57] [58] [59] and six as yet botanically undescribed 18, 22, 24, 25, 60, 61 species, only four taxa were found to contain naphthylisoquinolines with a fully dehydrogenated isoquinoline subunit. 20, 21, [26] [27] [28] [29] [30] Furthermore, 6-O-methylhamateine (4) and ancistrobreveine C (14) have proven to be potent bioactive compounds displaying good to strong inhibitory effects against drug-sensitive (CCRF-CEM) and multidrug-resistant (CEM/ADR5000) leukemia cells. Since the efficiency of many recommended drugs routinely used for the treatment of malignant disorders is threatened by the increasing emergence of resistance, 39-45 the development of new potent agents preventing the overexpression of Pgp is an important goal. The promising antiproliferative activities of fully dehydrogenated naphthylisoquinoline alkaloids warrant more-in-depth studies regarding their potential as effective MDR suppressors. This work is in progress.
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